Endo Pharmaceuticals Holdings Inc. 15,000,000 Shares Common Stock ($.01 par value) Underwriting AgreementEndo Pharmaceuticals Holdings Inc • January 23rd, 2006 • Pharmaceutical preparations • New York
The persons named in Schedule I hereto (the “Selling Stockholders”), propose to sell to Citigroup Global Markets Inc. (the “Underwriter”), 15,000,000 shares of Common Stock, $.01 par value (“Common Stock”), of Endo Pharmaceuticals Holdings Inc., a corporation organized under the laws of Delaware (the “Company”) (said shares to be sold by the Selling Stockholders being hereinafter called the “Underwritten Securities”). The Selling Stockholders also propose to grant to the Underwriter an option to purchase up to 2,225,000 additional shares of Common Stock to cover over-allotments (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). The Securities include shares of Common Stock (collectively, the “Stock Option Shares”) to be acquired by certain Selling Stockholders identified in Schedule I hereto (the “Stock Option Selling Stockholders”) upon exercise of currently outstanding options to purchase Common Stoc
SHELF REGISTRATION AGREEMENTShelf Registration Agreement • January 23rd, 2006 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New York
AGREEMENT, dated as of January 19, 2006 by and among Endo Pharmaceuticals Holdings Inc. (the “Company”), Endo Pharma LLC (the “LLC”) and the management stockholders signatory hereto (the “Management Stockholders”, and together with the Company and the LLC, the “Parties”).
